openPR Logo
Press release

Cellular Encapsulation By Key Players Overview (Austrianova Singapore Pte Ltd, Beta-Cell NV, Eli Lilly and Sigilon, Novo Nordisk, Semma Therapeutics, evotec, Living Cell Technologies Limited, Neurotech Pharmaceuticals, Inc. etc.)

01-22-2019 08:51 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Cellular Encapsulation By Key Players Overview (Austrianova

Cellular Encapsulation Market: Overview

Cellular encapsulation is an advanced method for the implantation of living cellular systems to provide unlimited drug delivery. Cellular encapsulation is used for major applications, including the immobilization of allogeneic or xenogeneic cells in semipermeable membranes and immune protective membranes to deliver biological products to patients without the need of immunosuppression, and for treating secretory cell dysfunction. Cellular encapsulation obviates the need for surgical procedures, reduces the burden of cell sourcing, and provides target drug delivery. The cellular encapsulation technique is used where the transplanted cells are protected from tissue rejection by enveloping the cells artificially, such as cell grafting. Delivering the therapeutic molecules across the blood brain barrier to the brain parenchyma is too difficult, and for resolving this issue, cellular encapsulation delivers the therapeutic molecules directly to the brain. A majority of the companies involved in cellular encapsulation are bringing in new technologies and advanced tissue engineering techniques to yield a well-established chemistry. Cellular encapsulation, on a broad category, includes microencapsulation and macro encapsulation, and these are the generally used types of cellular encapsulation in alginate hydrogels. The end user segments of cellular encapsulation include research centers and institutes, diagnostic laboratories, and pharmaceutical and biotechnology companies.

Get Free Exclusive Sample Copy of This Report @ 

Cellular Encapsulation Market: Drivers and Restraints

The increased use of cellular encapsulation for the controlled delivery of biological therapeutics is expected to drive revenue generation in the global cellular encapsulation market. There is increasing demand for cellular encapsulation in new applications for emerging fields such as tissue engineering. The cellular encapsulation method is being used for future developments, which includes developing artificial organs by a combination of 3D material and cell complexes, use of stem cells for drug delivery, delivery of enzymes, and tissue integration. Cellular encapsulation provides different therapeutic strategies for regenerative medicine, along with growing applications in tissue engineering, which are other important factors that are contributing to the growth of global cellular encapsulation market. The increasing number of incidences of various types of cancers, such as pancreatic cancer, breast cancer, and brain tumor, and high prevalence of diabetes are expected to push the growth of cellular encapsulation technology to develop treatments for cancer and diabetes, and this is fuelling the growth of the global cellular encapsulation technology market. However, scientific development, ethical obstacles, government regulations, and market forces are expected to restrain the growth of the global cellular encapsulation market.

Cellular Encapsulation Market: Overview

The global market for cellular encapsulation is expected to generate significant revenue with moderate growth over the forecast period. With full-scale replacements of defective tissues, cell transplants, and other applications, there exists high competition among local and regional players in the cellular encapsulation market. Among the different polymer types, cellular encapsulation including hyaluronic acid, alginate, agarose, siliceous encapsulate, cellulose sulphate, chitosan, and other polymers have been used for encapsulation. The research centers and institutes segment in the end user segments is expected to contribute high revenue share in the global cellular encapsulation market, as a majority of the demand is generated from this end user segment. 

Ask For Customized Report @

Cellular Encapsulation Market: Regional Outlook

Geographically, the global cellular encapsulation market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). Among these, North America is expected to be the dominant regional market for cellular encapsulation, owing to the high presence of huge manufacturing bases and constant technological advancements in the molecular testing field. Also, the set-up of numerous research laboratories in the region is further expected to drive revenue generation in the region over forecast period, attributed to the increasing prevalence of diabetes and cardiac diseases. The market in Asia Pacific excluding Japan is expected to grow at a moderate CAGR, due to the expanding footprint of domestic players. Europe is expected to register the second-largest share in the global cellular encapsulation market. 

Cellular Encapsulation Market: Key Players

The global cellular encapsulation market registers the presence of a large number of domestic manufacturers. Examples of some of the key players operating in the market are Austrianova Singapore Pte Ltd, Beta-Cell NV, Eli Lilly and Sigilon, Novo Nordisk, Semma Therapeutics, evotec, Living Cell Technologies Limited, Neurotech Pharmaceuticals, Inc., NovaMatrix, PharmaCyte Biotech, Inc., Sigma-Aldrich Co. LLC., and ViaCyte, Inc., among others.

For more information on this report, please visit:

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Follow Us on Linkedin:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cellular Encapsulation By Key Players Overview (Austrianova Singapore Pte Ltd, Beta-Cell NV, Eli Lilly and Sigilon, Novo Nordisk, Semma Therapeutics, evotec, Living Cell Technologies Limited, Neurotech Pharmaceuticals, Inc. etc.) here

News-ID: 1519971 • Views: 967

More Releases from Fact.MR

07-02-2020 | Health & Medicine
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
03-20-2020 | Health & Medicine
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On

All 5 Releases

More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Global Cell Therapy Market & Cell Therapy Clinical Pipeline Outlook 2022
The cell therapy industry is rapidly growing industry with the several new products that having been accepted for clinical use over the past few years. There are many challenges that need to be resolved wisely before the cell therapies are widely accepted, including the optimization of their manufacture. There is much to be explored about the specific features of the stem cells and about the efficacy and safety of the
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of